We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Volume 13, Issue 15 / November 2012

News & ViewsFree
November 2012
News & Views in ... Pharmacogenomics
  • Pages:1675–1677
  • Published Online:21 November 2012
News & Views
November 2012
Company Profile: Labceutics
  • Pages:1685–1688
  • Published Online:21 November 2012
Research Article
November 2012
Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients
  • Pages:1689–1700
  • Published Online:21 November 2012
Research Article
November 2012
DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients
  • Pages:1701–1710
  • Published Online:21 November 2012
Research Article
November 2012
Losartan hydroxylation phenotype in an Ecuadorian population: influence of CYP2C9 genetic polymorphism, habits and gender
  • Pages:1711–1717
  • Published Online:21 November 2012
Review
November 2012
Pharmacogenomics of opioids and perioperative pain management
  • Pages:1719–1740
  • Published Online:21 November 2012
Review
November 2012
Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning
  • Pages:1741–1757
  • Published Online:21 November 2012
Review
November 2012
Pharmacogenomic considerations of xenograft mouse models of acute leukemia
  • Pages:1759–1772
  • Published Online:21 November 2012
Review
November 2012
Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study
  • Pages:1773–1782
  • Published Online:21 November 2012
AcknowledgementsFree
November 2012
Acknowledgements
  • Page:1783
  • Published Online:21 November 2012